Complexes of hydroxy(thio)pyrone and hydroxy(thio)pyridinone with Zn(II) and Mo(VI). Thermodynamic stability and insulin-mimetic activity

Metallomics

Volumn 2, Issue 3, 2010, Pages 220-227

  Chaves, Sílvia ^a   Jelic, Ratomir ^a,b   Mendonça, Catarina ^a   Carrasco, Marta ^a   Yoshikawa, Yutaka ^c   Sakuraid, Hiromu ^d   Santos, M Amélia ^a  

^a INSTITUTO SUPERIOR TÉCNICO   (Portugal)

^b Faculty of Science   (Serbia)

^c KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^d SUZUKA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 DIMETHYL 3 HYDROXY 4 PYRIDINONE; 1,2 DIMETHYL 3 HYDROXYPYRIDINE 4 THIONE; CHELATING AGENT; MALTOL; METAL COMPLEX; MOLYBDENUM; MOLYBDENUM COMPLEX; MOLYBDENUM DMHP COMPLEX; MOLYBDENUM DMHTP COMPLEX; MOLYBDENUM MALTOL COMPLEX; MOLYBDENUM THIOMALTOL COMPLEX; SULFUR; THIOMALTOL; UNCLASSIFIED DRUG; ZINC COMPLEX; ZINC DMHP COMPLEX; ZINC DMHTP COMPLEX; ZINC ION; ZINC MALTOL COMPLEX; ZINC THIOMALTOL COMPLEX;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; DIABETES MELLITUS; INSULIN LIKE ACTIVITY; LIGAND BINDING; LIPOPHILICITY; NONHUMAN; PH; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RAT; SPECIES DIFFERENTIATION; STOICHIOMETRY; STRUCTURE ACTIVITY RELATION; THERMODYNAMICS; THERMOSTABILITY;

ADIPOCYTES; ANIMALS; DRUG STABILITY; EPINEPHRINE; FATTY ACIDS, NONESTERIFIED; HYDROGEN-ION CONCENTRATION; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; HYPOGLYCEMIC AGENTS; INSULIN; MOLYBDENUM; PHYSICOCHEMICAL PHENOMENA; PYRIDONES; PYRONES; RATS; RATS, WISTAR; SULFUR COMPOUNDS; THERMODYNAMICS; ZINC COMPOUNDS;

EID: 77953656441     PISSN: 17565901     EISSN: 1756591X     Source Type: Journal    
DOI: 10.1039/b914169c     Document Type: Article

References (38)

1. K. H. Thompson, J. Chiles, V. G. Yuen, J. Tse, J. H. McNeill and C. Orvig, J. Biol. Inorg. Chem., 2004, 9, 683-690.
2. H. Sakurai, Expert Opin. Drug Discovery, 2007, 2, 873-887.
3. K. H. Thompson, J. H. McNeill and C. Orvig, Chem. Rev., 1999, 99, 2561-2671.
4. M. Anke, Anal. Real Acad. Nac. Farm., 2004, 70, 961-999.
5. P. Trumbo, A. A. Yates, S. Schlicker and M. Poos, J. Am. Diet. Assoc., 2001, 101, 294-301.
6. J. Li, G. Elberg, D. Gefel and Y. Shechter, Biochemistry, 1995, 34, 6218-6225.
7. Y. Goto, K. Kida, M. Ikeuchi, Y. Kaino and H. Matsuda, Biochem. Pharmacol., 1992, 44, 174-177.
8. A. Sigel and H. Sigel, Molybdenum and Tungsten: Their Roles in Biological Processes, in Metal Ions in Biological Systems, Marcel Dekker, New York, 2002, vol. 39, p. 810.
9. R. Hille, Chem. Rev., 1996, 96, 2757-281.
10. Y. Adachi, J. Yoshida, Y. Kodera, T. Kiss, T. Jakusch, E. A. Enyedy, Y. Yoshikawa and H. Sakurai, Biochem. Biophys. Res. Commun., 2006, 351, 165-70.
11. Z. D. Liu and R. C. Hider, Coord. Chem. Rev., 2002, 232, 151-171.
12. M. A. Santos, M. Gil, L. Gano and S. Chaves, J. Biol. Inorg. Chem., 2005, 10, 564-580.
13. M. A. Santos, Coord. Chem. Rev., 2008, 252, 1213-1224.
14. R. C. Hider, L. Ejim, P. D. Taylor, R. Gale, E. Huelns and J. B. Porter, Biochem. Pharmacol., 1990, 39, 1005-1012.
15. K. H. Thompson and C. Orvig, J. Chem. Soc., Dalton Trans., 2000, 2885-2892.
16. Y. Yoshikawa, E. Uedo, H. Miyaki, H. Sakurai and Y. Koshima, Biochem. Biophys. Res. Commun., 2001, 281, 1190-1193.
17. S. L. Lord, N. A. Epstein, R. L. Paddock, C. M. Vogels, T. L. Hennigar, M. J. Zawaoroto, N. J. Taylor, W. R. Driedzic, T. L. Broderick and S. A.Wescott, Can. J. Chem., 1999, 77, 1249-1261.
18. A. Katoh, Y. Matsumura, Y. Yoshikawa, H. Yasui and H. Sakurai, J. Inorg. Biochem., 2009, 103, 567-574.
19. Purification of Laboratory Chemicals, ed. W. L. F. Armarego and D. D. Perrin, Butterworth-Heinemann Press, Oxford, 4th edn, 1999.
20. S. Chaves, M. Gil, S. Canário, R. Jelic, M. J. Romão, J. Trincão, E. Herdtweck, J. Sousa, C. Diniz, P. Fresco and M. A. Santos, Dalton Trans., 2008, 1773-1782.
21. S. Chaves, S. M. Marques, A. Cachudo, M. A. Esteves and M. A. Santos, Eur. J. Inorg. Chem., 2006, 3853-3860.
22. P. Gans, A. Sabatini and A. Vacca, Talanta, 1996, 43, 1739-1753.
23. R. M. Smith and A. E. Martell, Critical Stability Constants, Plenum, New York, 1976, vol. 4, p. 9.
24. A. Leo, C. Hansch and D. Elkins, Chem. Rev., 1971, 71, 525-616.
25. M. Nakai, H. Watanabe, C. Fujisawa, H. Kakegawa, T. Satoh, J. Takada, R. Matsushita and H. Sakurai, Biol. Pharm. Bull., 1995, 18, 719-725.
26. B. Song, N. Aebischer and C. Orvig, Inorg. Chem., 2002, 41, 1357-1364.
27. T. Jakusch, K. Gajda-Schrantz, Y. Adachi, H. Sakurai, T. Kiss and L. Horváth, J. Inorg. Biochem., 2006, 100, 1521-1526.
28. J. A. Lewis, B. L. Tran, D. T. Puerta, E. M. Rumberger, D. N. Hendrickson and S. M. Cohen, Dalton Trans., 2005, 2588-2596.
29. V. Monga, B. O. Patrick and C. Orvig, Inorg. Chem., 2005, 44, 2666-2677.
30. R. Yokel, A. K. Datta and E. G. Jackson, J. Pharmacol. Exp. Ther., 1991, 257, 100-106.
31. Y. Adachi, J. Yoshida, Y. Kodera, A. Kato, Y. Yoshikawa, Y. Kojima and H. Sakurai, J. Biol. Inorg. Chem., 2004, 9, 885-893.
32. M. A. Santos, S. Gama, J. C. Pessoa, M. C. Oliveira, I. Tóth I and E. Farkas, Eur. J. Inorg. Chem., 2007, 1728-1737.
33. A. Nakayama, M. Hiromura, Y. Adachi and H. Sakurai, J. Biol. Inorg. Chem., 2008, 13, 675-684.
34. W. Basuki, M. Hiromura and H. Sakurai, J. Inorg. Biochem., 2007, 101, 692-699.
35. H. Sakurai, Y. Kojima, Y. Yoshikawa, K. Kawabe and H. Yasui, Coord. Chem. Rev., 2002, 226, 187-198.
36. D. Rehder, Inorg. Chem. Commun., 2003, 6, 604-617.
37. M. Rangel, A. Tamura, C. Fukushima and H. Sakurai, J. Biol. Inorg. Chem., 2001, 6, 128-132.
38. Y. Zheng, X.-K. Li, Y. Wang and L. Cai, Hemoglobin, 2008, 32, 135-145.